Cardiogenic shock complicating ST-elevation myocardial infarction: a very difficult clinical scenario

Area of Science:

• Cardiology
• Critical Care Medicine

Background:

• Cardiogenic shock (CS) complicates 5-15% of acute myocardial infarctions (AMI).
• Despite advances, CS incidence remains unchanged, with over 50% mortality.
• CS is the primary cause of AMI-related in-hospital mortality.

Purpose of the Study:

• To provide a comprehensive overview of cardiogenic shock in acute myocardial infarction.
• To detail the pathophysiology, etiology, and clinical course of CS.
• To outline current medical and interventional management strategies for CS complicating AMI.

Main Methods:

• Literature review and synthesis of existing research on cardiogenic shock.
• Analysis of epidemiological data regarding CS incidence and mortality.
• Compilation of current guidelines and evidence-based practices for CS management.

Main Results:

• CS pathophysiology involves complex interactions leading to pump failure.
• Etiologies of CS in AMI are diverse, often related to infarct size and location.
• Management requires a multi-faceted approach including hemodynamic support and revascularization.

Conclusions:

• Cardiogenic shock remains a critical complication of AMI with high mortality.
• Early recognition and timely, aggressive management are crucial for improving outcomes.
• Continued research into novel therapies and strategies is essential for reducing CS-related deaths.